144 related articles for article (PubMed ID: 30952448)
1. Weight change and blood glucose concentration as markers for pancreatic cancer in subjects with new-onset diabetes mellitus: A matched case-control study.
Mueller AM; Meier CR; Jick SS; Schneider C
Pancreatology; 2019 Jun; 19(4):578-586. PubMed ID: 30952448
[TBL] [Abstract][Full Text] [Related]
2. The Potential of Glycemic Control and Body Weight Change as Early Markers for Pancreatic Cancer in Patients With Long-standing Diabetes Mellitus: A Case-Control Study.
Mueller AM; Meier CR; Jick SS; Schneider C
Pancreas; 2018 Aug; 47(7):807-815. PubMed ID: 29975346
[TBL] [Abstract][Full Text] [Related]
3. Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss.
Škrha J; Bušek P; Uhrová J; Hrabal P; Kmochová K; Laclav M; Bunganič B; Frič P
Pancreatology; 2017; 17(1):89-94. PubMed ID: 28027898
[TBL] [Abstract][Full Text] [Related]
4. BMI and HbA1c are metabolic markers for pancreatic cancer: Matched case-control study using a UK primary care database.
Lemanska A; Price CA; Jeffreys N; Byford R; Dambha-Miller H; Fan X; Hinton W; Otter S; Rice R; Stunt A; Whyte MB; Faithfull S; de Lusignan S
PLoS One; 2022; 17(10):e0275369. PubMed ID: 36197912
[TBL] [Abstract][Full Text] [Related]
5. New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer.
Lu Y; García Rodríguez LA; Malgerud L; González-Pérez A; Martín-Pérez M; Lagergren J; Bexelius TS
Br J Cancer; 2015 Dec; 113(11):1607-14. PubMed ID: 26575601
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic β Cell Dedifferentiation in Nondiabetic Patients with Pancreatic Cancer.
Wang Y; Ni Q; Sun J; Xu M; Xie J; Zhang J; Fang Y; Ning G; Wang Q
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31781763
[TBL] [Abstract][Full Text] [Related]
7. Weight loss precedes cancer-specific symptoms in pancreatic cancer-associated diabetes mellitus.
Hart PA; Kamada P; Rabe KG; Srinivasan S; Basu A; Aggarwal G; Chari ST
Pancreas; 2011 Jul; 40(5):768-72. PubMed ID: 21654538
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the deterioration of diabetes control in patients with a subsequent diagnosis of pancreatic cancer: A descriptive study.
Mueller AM; Meier CR; Jick SS; Schneider C
Pancreatology; 2022 Apr; 22(3):387-395. PubMed ID: 35314354
[TBL] [Abstract][Full Text] [Related]
9. Pattern of increasing HbA1c levels in patients with diabetes mellitus before clinical detection of pancreatic cancer - a population-based nationwide case-control study.
Sadr-Azodi O; Gudbjörnsdottir S; Ljung R
Acta Oncol; 2015 Jul; 54(7):986-92. PubMed ID: 25734801
[TBL] [Abstract][Full Text] [Related]
10. New-Onset Diabetes, Longitudinal Trends in Metabolic Markers, and Risk of Pancreatic Cancer in a Heterogeneous Population.
Huang BZ; Pandol SJ; Jeon CY; Chari ST; Sugar CA; Chao CR; Zhang ZF; Wu BU; Setiawan VW
Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1812-1821.e7. PubMed ID: 31809917
[TBL] [Abstract][Full Text] [Related]
11. Glycaemic, weight, and blood pressure changes associated with early versus later treatment intensification with dapagliflozin in United Kingdom primary care patients with type 2 diabetes mellitus.
Wilding JPH; Rigney U; Blak BT; Nolan ST; Fenici P; Medina J
Diabetes Res Clin Pract; 2019 Sep; 155():107791. PubMed ID: 31325543
[TBL] [Abstract][Full Text] [Related]
12. Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study.
de Ritter R; Sep SJS; van der Kallen CJH; Schram MT; Koster A; Kroon AA; van Greevenbroek MMJ; Eussen SJPM; Dagnelie PC; de Jong M; Vos RC; Woodward M; Bots ML; Peters SAE; Stehouwer CDA
BMJ Open Diabetes Res Care; 2019; 7(1):e000787. PubMed ID: 31798903
[TBL] [Abstract][Full Text] [Related]
13. The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a case-control study.
Ben Q; Cai Q; Li Z; Yuan Y; Ning X; Deng S; Wang K
Eur J Cancer; 2011 Jan; 47(2):248-54. PubMed ID: 20709528
[TBL] [Abstract][Full Text] [Related]
14. Diabetes duration and weight loss are associated with onset age and remote metastasis of pancreatic cancer in patients with diabetes mellitus.
Ma M; Li W; Xu L; Ping F; Zhang H; Li Y
J Diabetes; 2022 Apr; 14(4):261-270. PubMed ID: 35167190
[TBL] [Abstract][Full Text] [Related]
15. Low circulating vitamin D levels are associated with increased arterial stiffness in prediabetic subjects identified according to HbA1c.
Zagami RM; Di Pino A; Urbano F; Piro S; Purrello F; Rabuazzo AM
Atherosclerosis; 2015 Dec; 243(2):395-401. PubMed ID: 26520892
[TBL] [Abstract][Full Text] [Related]
16. Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
Grote VA; Rohrmann S; Nieters A; Dossus L; Tjønneland A; Halkjær J; Overvad K; Fagherazzi G; Boutron-Ruault MC; Morois S; Teucher B; Becker S; Sluik D; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Pala V; Tumino R; Vineis P; Panico S; Rodríguez L; Duell EJ; Molina-Montes E; Dorronsoro M; Huerta JM; Ardanaz E; Jeurnink SM; Beulens JW; Peeters PH; Sund M; Ye W; Lindkvist B; Johansen D; Khaw KT; Wareham N; Allen N; Crowe F; Jenab M; Romieu I; Michaud DS; Riboli E; Romaguera D; Bueno-de-Mesquita HB; Kaaks R
Diabetologia; 2011 Dec; 54(12):3037-46. PubMed ID: 21953276
[TBL] [Abstract][Full Text] [Related]
17. Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study.
Au Yeung SL; Schooling CM
BMJ Open Diabetes Res Care; 2019; 7(1):e000872. PubMed ID: 31908803
[TBL] [Abstract][Full Text] [Related]
18. Type 2 diabetes mellitus and CA 19-9 levels.
Uygur-Bayramicli O; Dabak R; Orbay E; Dolapcioglu C; Sargin M; Kilicoglu G; Guleryuzlu Y; Mayadagli A
World J Gastroenterol; 2007 Oct; 13(40):5357-9. PubMed ID: 17879406
[TBL] [Abstract][Full Text] [Related]
19. The use of glycated haemoglobin (HbA1
Mustafa IO; Tanko Y; Yusuf R; Musa SA
Diabetes Metab Syndr; 2019; 13(5):2967-2972. PubMed ID: 31437811
[TBL] [Abstract][Full Text] [Related]
20. Effect of once-weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c.
Gallwitz B; Dagogo-Jack S; Thieu V; Garcia-Perez LE; Pavo I; Yu M; Robertson KE; Zhang N; Giorgino F
Diabetes Obes Metab; 2018 Feb; 20(2):409-418. PubMed ID: 28817231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
